300482 萬孚生物
按盤價 
25.030 +0.090 (+0.361%)
25.030 +0.090 (+0.361%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.731 | 11.007 | 31.105 | 20.481 | 25.038 |
| 總資產報酬率 ROA (%) | 6.963 | 8.078 | 21.458 | 13.849 | 17.494 |
| 投入資產回報率 ROIC (%) | 7.636 | 9.139 | 25.310 | 16.723 | 21.829 | 邊際利潤分析 |
| 銷售毛利率 (%) | 63.432 | 62.611 | 51.824 | 58.463 | 69.022 |
| 營業利潤率 (%) | 22.835 | 19.861 | 24.078 | 20.586 | 26.330 |
| 息稅前利潤/營業總收入 (%) | 23.253 | 19.326 | 24.009 | 21.702 | 26.999 |
| 淨利潤/營業總收入 (%) | 20.162 | 17.629 | 20.951 | 18.821 | 21.944 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.480 | 86.963 | 98.971 | 88.859 | 109.869 |
| 價值變動淨收益/利潤總額(%) | 5.354 | 8.488 | 5.319 | 8.526 | 4.403 |
| 營業外收支淨額/利潤總額(%) | -1.070 | -1.549 | -0.235 | -1.677 | -1.253 | 償債能力分析 |
| 流動比率 (X) | 7.444 | 6.677 | 2.936 | 3.266 | 2.861 |
| 速動比率 (X) | 6.670 | 5.952 | 2.586 | 2.778 | 2.387 |
| 資產負債率 (%) | 17.532 | 20.048 | 27.988 | 27.838 | 0.305 |
| 帶息債務/全部投入資本 (%) | 9.396 | 11.762 | 18.144 | 15.825 | 18.987 |
| 股東權益/帶息債務 (%) | 944.483 | 730.796 | 441.986 | 524.162 | 422.286 |
| 股東權益/負債合計 (%) | 462.239 | 390.286 | 246.313 | 248.056 | 216.562 |
| 利息保障倍數 (X) | 35.224 | -83.428 | -1,954.013 | 14.910 | 27.132 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 91.736 | 74.110 | 32.907 | 41.111 | 44.055 |
| 存貨周轉天數 (天) | 125.634 | 130.828 | 51.713 | 98.364 | 124.084 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 12:40 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
